Atlas Trials

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

Clinical trial NCT05893966 · RECRUITING

Trial details

NCT number
NCT05893966
Sponsor
Samsung Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Breast Cancer
Start date
2022-11-29
Primary completion
2030-11-29
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.